Ventricular Tachycardia

Clinical Trial Finder

Many patients with ventricular tachycardia are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia

Condition:   Monomorphic Ventricular Tachycardia
Intervention:   Device: Cardiac catheter ablation with ICD/CRT-D
Sponsor:   St. Jude Medical
Active, not recruiting - verified January 2016

Ultra-high Density Mapping With Multielectrode Catheter vs Conventional Point by Point Mapping for Ventricular Tachycardia Substrate Ablation

Condition:   Ventricular Tachycardia
Interventions:   Device: Ablation guided by conventional mapping.;   Device: Ablation guided by ultra-high density mapping with multielectrode catheter.
Sponsor:   Hospital Clinic of Barcelona
Active, not recruiting - verified January 2016

Renal Denervation In Patient Undergoing VT Ablation:Combined Renal Denervation and VT Ablation vs. Simply VT Ablation

Conditions:   Ventricular Tachycardia;   Cardiomyopathy
Interventions:   Procedure: Ablation of ventricular arrhythmias;   Procedure: Ablation of ventricular arrhythmias + renal denervation
Sponsors:   Universitätsklinikum Hamburg-Eppendorf;   Medtronic
Terminated - verified February 2016

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure

Condition:   Current or Recent History of Atrial Fibrillation
Interventions:   Drug: bucindolol hydrochloride;   Drug: metoprolol succinate
Sponsors:   ARCA Biopharma, Inc.;   Medtronic
Recruiting - verified February 2016

Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.

Conditions:   Heart Failure;   Left Ventricular Systolic Dysfunction
Interventions:   Device: ICD;   Device: ILR
Sponsors:   Flinders University;   South Australian Health and Medical Research Institute
Recruiting - verified February 2016

Ventricular Tachycardia (VT) Ablation Versus Enhanced Drug Therapy

Condition:   Recurrent Ventricular Tachycardia
Interventions:   Procedure: Catheter Ablation;   Drug: Aggressive Antiarrhythmic Therapy (Amiodarone)
Sponsors:   John Sapp;   St. Jude Medical;   Biosense Webster, Inc.;   Canadian Institutes of Health Research (CIHR)
Completed - verified January 2016